Genetic factors and cancer: diagnosis, prognosis and future perspectives

Main Article Content

Fernando Russo Costa do Bomfim
https://orcid.org/0000-0002-2614-3603

Abstract

Genetics is specifically responsible for several pathologies or, at the least, it is associated with a wide range of them, either as a primary causal agent (congenital genetic diseases) or secondary, being a factor within several possible for a given disease. One of the most critical genetic concepts is developed from the phenotype, equivalent to the genotype associated with the environment. In other words, for a condition to manifest itself, cancer, for example, we need a genetic alteration within the environment, which somehow influences carcinogenesis from stochastic or induced interactions. Cancer cases are approximately 80% and 90% associated with external causes, and environmental changes are mainly motivated by human actions, habits, and behavior, leading to an increased risk of different types of cancer. These changes lead to the formation of a cycle since man promotes environmental changes, leading to genetic modifications responsible for 10-20% of cancer formation. Although the percentage seems not to be significant, we have, in fact, several genetic mechanisms that will lead to the emergence of the most diverse types of cancer, including polymorphisms, mutations, oxidative stress, oncogenes, and genes that regulate the cell cycle, including apoptosis.



Article Details

How to Cite
1.
Bomfim FRC do. Genetic factors and cancer: diagnosis, prognosis and future perspectives. Health Sci J [Internet]. 2021Sep.29 [cited 2024Apr.20];11(3):1-. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1218
Section
EDITORIAL
Author Biography

Fernando Russo Costa do Bomfim, University Center of the Hermínio Ometto Foundation

PhD, Professor of Molecular Biology at the University Center of Fundação Hermínio Ometto (FHO), Araras, São Paulo, Brazil. Postdoctoral fellow at the Federal University of São Paulo / EPM. São Paulo, São Paulo, Brazil.

References

1. Brasil, Ministério da Saúde, Instituto Nacional de Câncer - INCA. Estatísticas de câncer. 2021. Disponível em: https://www.inca.gov.br/numeros-de-cancer
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660 PMid:33538338
3. Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 2018;26(2):158-68. https://doi.org/10.1016/j.tim.2017.07.007 PMid:28823569
4. Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer. 2020;20(8):471-80. https://doi.org/10.1038/s41568-020-0262-1 PMid:32404993
5. Gorodetska I, Kozeretska I, Dubrovska A. BRCA Genes: The role in genome stability, cancer stemness and therapy resistance. J Cancer. 2019;10(9):2109-27. https://doi.org/10.7150/jca.30410 PMid:31205572 PMCid:PMC6548160
6. Cao J, Yan Q. Cancer Epigenetics, Tumor Immunity, and Immunotherapy. Trends Cancer. 2020;6(7):580-92. https://doi.org/10.1016/j.trecan.2020.02.003 PMid:32610068 PMCid:PMC7330177